FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2112161217> ?p ?o ?g. }

• W2112161217 endingPage "1559" @default.
• W2112161217 startingPage "1547" @default.
• W2112161217 abstract "To evaluate the safety profile and efficacy of alpha1-adrenergic receptor blockers (A1Bs) currently prescribed for benign prostatic hyperplasia (BPH).A systematic literature search of MEDLINE, the Cochrane Database and the Food and Drug Administration Web site through December 2006 identified double-blinded, prospective, placebo-controlled trials, evaluating agents commercially available by prescription for the symptomatic treatment of BPH.Data were reviewed by two investigators with the use of a standardised data abstraction form. Studies were evaluated for methodological quality using the Jadad scale. Studies with a score of < 3 were considered of weaker methodology.Of 2389 potential citations, 25 were usable for evaluation of safety data, 26 for efficacy. A1B use was associated with a statistically significant increase in the odds of developing a vascular-related event [odds ratio (OR) 2.54; 95% confidence interval (CI): 2.00-3.24; p < 0.0001]. The odds of developing a vascular-related adverse event were: alfuzosin, OR 1.66, 95% CI: 1.17-2.36; terazosin, OR 3.71, 95% CI: 2.48-5.53; doxazosin, OR 3.32, 95% CI: 2.10-5.23 and tamsulosin, OR 1.42, 95% CI: 0.99-2.05. A1Bs increased Q(max) by 1.32 ml/min (95% CI: 1.07-1.57) compared with placebo. Difference from placebo in American Urological Association symptom index/International Prostate Symptom Score was -1.92 points (95% CI: -2.71 to -1.14).Alfuzosin, terazosin and doxazosin showed a statistically significant increased risk of developing vascular-related events compared with placebo. Tamsulosin showed a numerical increase that was not statistically significant. All agents significantly improved Q(max) and symptom signs compared with placebo." @default.
• W2112161217 created "2016-06-24" @default.
• W2112161217 creator A5002110010 @default.
• W2112161217 creator A5034811772 @default.
• W2112161217 creator A5068720436 @default.
• W2112161217 date "2008-09-08" @default.
• W2112161217 modified "2023-10-10" @default.
• W2112161217 title "A meta-analysis of the vascular-related safety profile and efficacy of α-adrenergic blockers for symptoms related to benign prostatic hyperplasia" @default.
• W2112161217 cites W1480729244 @default.
• W2112161217 cites W1966345715 @default.
• W2112161217 cites W1966674905 @default.
• W2112161217 cites W1967199121 @default.
• W2112161217 cites W1972271188 @default.
• W2112161217 cites W1983391475 @default.
• W2112161217 cites W1986215651 @default.
• W2112161217 cites W1990559364 @default.
• W2112161217 cites W1991011333 @default.
• W2112161217 cites W1991309369 @default.
• W2112161217 cites W1993767747 @default.
• W2112161217 cites W2002058762 @default.
• W2112161217 cites W2009217029 @default.
• W2112161217 cites W2009329619 @default.
• W2112161217 cites W2012255069 @default.
• W2112161217 cites W2014040958 @default.
• W2112161217 cites W2015428726 @default.
• W2112161217 cites W2017365683 @default.
• W2112161217 cites W2017800674 @default.
• W2112161217 cites W2021270740 @default.
• W2112161217 cites W2025315044 @default.
• W2112161217 cites W2026422425 @default.
• W2112161217 cites W2029280248 @default.
• W2112161217 cites W2031436110 @default.
• W2112161217 cites W2033451677 @default.
• W2112161217 cites W2038693293 @default.
• W2112161217 cites W2042712431 @default.
• W2112161217 cites W2047079119 @default.
• W2112161217 cites W2052122168 @default.
• W2112161217 cites W2057806510 @default.
• W2112161217 cites W2058720768 @default.
• W2112161217 cites W2072155356 @default.
• W2112161217 cites W2088103466 @default.
• W2112161217 cites W2090295903 @default.
• W2112161217 cites W2095304582 @default.
• W2112161217 cites W2100007591 @default.
• W2112161217 cites W2101665942 @default.
• W2112161217 cites W2112339576 @default.
• W2112161217 cites W2116288141 @default.
• W2112161217 cites W2121759271 @default.
• W2112161217 cites W2123527069 @default.
• W2112161217 cites W2135421268 @default.
• W2112161217 cites W2138705852 @default.
• W2112161217 cites W2157823046 @default.
• W2112161217 cites W2331302678 @default.
• W2112161217 cites W2341507669 @default.
• W2112161217 cites W2400376596 @default.
• W2112161217 cites W2413445666 @default.
• W2112161217 cites W2419306660 @default.
• W2112161217 cites W2460124600 @default.
• W2112161217 cites W2475283203 @default.
• W2112161217 cites W2907622422 @default.
• W2112161217 cites W4236163484 @default.
• W2112161217 cites W4319720823 @default.
• W2112161217 doi "https://doi.org/10.1111/j.1742-1241.2008.01880.x" @default.
• W2112161217 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2658011" @default.
• W2112161217 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18822025" @default.
• W2112161217 hasPublicationYear "2008" @default.
• W2112161217 type Work @default.
• W2112161217 sameAs 2112161217 @default.
• W2112161217 citedByCount "125" @default.
• W2112161217 countsByYear W21121612172012 @default.
• W2112161217 countsByYear W21121612172013 @default.
• W2112161217 countsByYear W21121612172014 @default.
• W2112161217 countsByYear W21121612172015 @default.
• W2112161217 countsByYear W21121612172016 @default.
• W2112161217 countsByYear W21121612172017 @default.
• W2112161217 countsByYear W21121612172018 @default.
• W2112161217 countsByYear W21121612172019 @default.
• W2112161217 countsByYear W21121612172020 @default.
• W2112161217 countsByYear W21121612172021 @default.
• W2112161217 countsByYear W21121612172022 @default.
• W2112161217 countsByYear W21121612172023 @default.
• W2112161217 crossrefType "journal-article" @default.
• W2112161217 hasAuthorship W2112161217A5002110010 @default.
• W2112161217 hasAuthorship W2112161217A5034811772 @default.
• W2112161217 hasAuthorship W2112161217A5068720436 @default.
• W2112161217 hasBestOaLocation W21121612171 @default.
• W2112161217 hasConcept C121608353 @default.
• W2112161217 hasConcept C126322002 @default.
• W2112161217 hasConcept C126894567 @default.
• W2112161217 hasConcept C136524200 @default.
• W2112161217 hasConcept C142724271 @default.
• W2112161217 hasConcept C156957248 @default.
• W2112161217 hasConcept C197934379 @default.
• W2112161217 hasConcept C204787440 @default.
• W2112161217 hasConcept C27081682 @default.
• W2112161217 hasConcept C2776235491 @default.
• W2112161217 hasConcept C2776478404 @default.
• W2112161217 hasConcept C2776547966 @default.

• next